Exelixis Inc
NASDAQ:EXEL 3:59:55 PM EDT
| Market Cap (Intraday) | 6.36B |
| Current PE | 67.64 |
| Forward PE | 33.9 |
| 2yr Forward PE | 21.64 |
| 10-Day MA | $20.23 |
| 50-Day MA | $18.51 |
| 200-Day MA | $21.37 |
Exelixis Inc Stock, NASDAQ:EXEL
1851 Harbor Bay, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 773
Description
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.